š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This study evaluates the safety and immunogenicity of the BPZE1 live attenu...
Status
Completed
Location
Rapid medical Research Inc
Start Date
2019-06-15
Trial ID
NCT03942406
Treatments Being Tested
The main purpose of the this study is to evaluate the safety and tolerabili...
Status
Completed
Location
Site 2
Start Date
2016-09
Trial ID
NCT02998996
This is a multi-center study in patients with un-resectable Recurrent or Me...
Status
Recruiting
Location
CRLC Val d'Aurelle - Institut de Recherche en Cancerologie de Montpellier (IRCM)
Start Date
2023-12-19
Trial ID
NCT06016920
Treatments Being Tested
This study will be a randomized, double-blind, placebo-controlled trial of ...
Status
Completed
Location
University Health Network, Toronto General Hospital
Start Date
2021-05-25
Trial ID
NCT04885907
Treatments Being Tested
This was a multicenter, stratified, open, randomized, comparator-controlled...
Status
Completed
Location
Cedars-Sinai Medical Center Samuel Oschin Cancer Center
Start Date
2012-09-06
Trial ID
NCT01578239
Treatments Being Tested
The trial is a randomized, double-blind First in Human trial to evaluate th...
Status
Completed
Location
Profil GmbH
Start Date
2014-12
Trial ID
NCT02367053
The primary objective is to assess the dose response versus placebo of a si...
Status
Completed
Location
Private practice
Start Date
2011-03
Trial ID
NCT01333397
Treatments Being Tested
This is a Phase I/II, randomised, multicentre, partially double-blind (grou...
Status
Completed
Location
Site 5
Start Date
2018-02-09
Trial ID
NCT03437304